Immunomodulatory Effect of Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation

Journal: Current Trends in Pharmacology and Clinical Trials PDF  

Published: April 08, 2019 Volume: 2 Issue: 1 Pages: 1-9

DOI:

Authors: Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, and Jana S

Citation: Trivedi MK, et al. Immunomodulatory Effect of Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation. Curr Trends Pharma Clinical Trials 2019, 2(1): 180015

  • 10 Views
  • Downloads

Abstract

Complementary medicines are accepting world-wide and are used extensively due to its safe and non-toxic nature. The aim of the study was to evaluate the immunomodulatory potential of the Biofield Energy Treated (known as The Trivedi Effect®) novel proprietary formulation and Biofield Energy Treatment per se on male rats. The formulation was divided into two parts, one part was defined as the untreated test formulation, while the other part was treated with the Biofield Energy by Mahendra Kumar Trivedi and denoted as the Biofield Energy Treated test formulation. Experimental groups (G) included G1 with normal control, G2 with disease control, G3 with the treatment of levamisole (positive control), G4 with untreated test formulation, G5 received Biofield Treated test formulation, G6 consisted of Biofield Energy Treatment per se to animals (-15 days), G7 received Biofield Treated test formulation from day -15, G8 has received Biofield Energy Treatment per se to animals along with Biofield Treated test formulation from day -15, and G9 received Biofield Energy Treatment per se to animals with the untreated test formulation.

The results showed that primary antibody titer value was significantly increased by 60%, 63.33%, 33.33%, and 20% in the G6, G7, G8, and G9 groups, respectively compared with the G2. However, secondary antibody titer values were significantly increased by 50%, 37.5%, 37.5%, and 12.5% in the G6, G7, G8, and G9 groups, respectively compared with the G2. Delayed type hypersensitivity (DTH) reaction showed significant increase level of rat paw volume by 86.36%, 30.68%, and 14.77% in the G5, G6, and G7 groups, respectively compared with the G2. Additionally, the platelet count was significantly increased by 11.96% in G6 compared to G2. The level of uric acid was significantly reduced by 64.29% in G7 compared to G2. Further, levels of calcium and phosphorous were significantly increased by 19.16% and 14.92%, respectively in the G9 compared to the G2.

Moreover, the level of magnesium was significantly increased by 13.11% and 10.66% in G4 and G9 groups, respectively compared to G2. Overall, data suggests that the Biofield Treatment per se (The Trivedi Effect®) and Biofield Treated test formulation have shown significant immunomodulatory action as compared with the untreated product and unblessed rats. Therefore, the Biofield Treatment could be utilised against various immuno-related disorders such as neutropenia, asplenia, trauma, sickle cell anemia, multiple myeloma, chronic lymphoid leukemia, stress, aging, etc.

Conclusion

The experimental results suggest that Biofield Treatment per se and the Biofield Energy Treated test formulation have shown significant immunomodulatory action with improved primary antibody titer values by 60%, 63.33%, 33.33%, and 20% in the G6, G7, G8, and G9 groups, respectively as compared with the disease control (G2) group. Moreover, the secondary antibody titer values in the G6, G7, G8, and G9 groups were also increased by 50%, 37.5%, 37.5%, and 12.5%, respectively, compared to the G2 group. Delayed type hypersensitivity data also suggest that there was an increased in rats paw volume by 86.36%, 30.68%, and 14.77% in the G5, G6, and G7 groups, respectively compared to the G2 group. Besides, hematological parameter like platelet counts was increased in the G6 group by 11.96% compared to the G2 group. Biochemical parameters like uric acid level was reduced in the G7 group (by 64.29%), increased the levels of calcium (by 19.16%) and phosphorous (by 14.92%) were increased in the G9 group, compared to the G2 group. Further, serum magnesium level was significantly increased by 13.11%, 9.84%, and 10.66% in the G4, G8, and G9 groups, respectively compared to the G2 group. Overall, data suggests that the Biofield Energy Treatment (The Trivedi Effect®) per se to the animals and Biofield Energy Treated test formulation showed an improved immune response as compared with the untreated test formulation. Therefore the Biofield Treatment can be used to fight against various immuno-related disorders such as neutropenia, asplenia, trauma, sickle cell anemia, multiple myeloma, chronic lymphoid leukemia, stress, aging, etc. Besides, it can also be used for the transplant of various organs (kidney, liver, and heart), autoimmune disorders (Systemic Lupus Erythematosus, Addison Disease, Graves’ Disease, Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, Rheumatoid Arthritis, Sjogren Syndrome, Alopecia Areata, Vasculitis, Type 1 Diabetes, Fibromyalgia, Crohn’s Disease, Vitiligo, Chronic Fatigue Syndrome Scleroderma, Psoriasis), and inflammatory disorders such as Diverticulitis, Ulcerative Colitis, Asthma, Alzheimer’s Disease, Atherosclerosis, Irritable Bowel Syndrome, Parkinson’s Disease Dermatitis, Hepatitis, and stress etc.